158 related articles for article (PubMed ID: 1693168)
1. The in-vitro response of CD2-positive acute myelogenous leukemia to proliferation and differentiation inducing agents.
Traweek ST; Ben-Ezra J; Braziel RM; Winberg CD
Leuk Res; 1990; 14(5):433-40. PubMed ID: 1693168
[TBL] [Abstract][Full Text] [Related]
2. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
3. Mature T-lineage leukemia with growth factor-induced multilineage differentiation.
Griesinger F; Arthur DC; Brunning R; Parkin JL; Ochoa AC; Miller WJ; Wilkowski CW; Greenberg JM; Hurvitz C; Kersey JH
J Exp Med; 1989 Mar; 169(3):1101-20. PubMed ID: 2538542
[TBL] [Abstract][Full Text] [Related]
4. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
5. [Cellular and biological characterization of CD7-positive acute leukemia cells--an investigation of the established cell line, HSM911].
Iwasaki H
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):750-66. PubMed ID: 7525434
[TBL] [Abstract][Full Text] [Related]
6. CD7+ acute non-lymphocytic leukemia: evidence for an early multipotential progenitor.
Zutter MM; Martin PJ; Hanke D; Kidd PG
Leuk Res; 1990; 14(1):23-6. PubMed ID: 1689436
[TBL] [Abstract][Full Text] [Related]
7. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
Ball ED; Davis RB; Griffin JD; Mayer RJ; Davey FR; Arthur DC; Wurster-Hill D; Noll W; Elghetany MT; Allen SL
Blood; 1991 May; 77(10):2242-50. PubMed ID: 1709379
[TBL] [Abstract][Full Text] [Related]
9. Maturation of acute T-lymphoblastic leukemia cells after CD2 ligation and subsequent treatment with interleukin-2.
Mentz F; Ouaaz F; Michel A; Blanc C; Hervé P; Bismuth G; Debré P; Merle-Béral H; Mossalayi MD
Blood; 1994 Aug; 84(4):1182-92. PubMed ID: 7519476
[TBL] [Abstract][Full Text] [Related]
10. CD7 positive hematopoietic progenitors and acute myeloid leukemia and other minimally differentiated leukemia.
Tien HF; Wang CH
Leuk Lymphoma; 1998 Sep; 31(1-2):93-8. PubMed ID: 9720718
[TBL] [Abstract][Full Text] [Related]
11. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
12. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
Naghashpour M; Lancet J; Moscinski L; Zhang L
Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
[TBL] [Abstract][Full Text] [Related]
13. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases.
Rozenova KA; Jevremovic D; Reichard KK; Nguyen P; Otteson GE; Timm MM; Horna P; Olteanu H; Shi M
Hum Pathol; 2021 Aug; 114():66-73. PubMed ID: 34019867
[TBL] [Abstract][Full Text] [Related]
14. A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7--morphologic, cytochemical, immunocytochemical and T cell receptor gene analysis on 13 patients.
Tien HF; Wang CH; Su IJ; Liu FS; Wu HS; Chen YC; Lin KH; Lee SC; Shen MC
Leuk Res; 1990; 14(6):515-23. PubMed ID: 1695699
[TBL] [Abstract][Full Text] [Related]
15. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
Cross AH; Goorha RM; Nuss R; Behm FG; Murphy SB; Kalwinsky DK; Raimondi S; Kitchingman GR; Mirro J
Blood; 1988 Aug; 72(2):579-87. PubMed ID: 3261183
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.
Adriaansen HJ; te Boekhorst PA; Hagemeijer AM; van der Schoot CE; Delwel HR; van Dongen JJ
Blood; 1993 Jun; 81(11):3043-51. PubMed ID: 8098967
[TBL] [Abstract][Full Text] [Related]
18. Biological characteristics of CD7 positive acute myelogenous leukaemia.
Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
[TBL] [Abstract][Full Text] [Related]
19. Co-ordinate expression of T-cell antigens on acute myelogenous leukemia and of myeloid antigens on T-acute lymphoblastic leukemia. Speculation on a highly balanced bilinearity.
Del Vecchio L; Finizio O; Lo Pardo C; Pane N; Schiavone EM; Vacca C; Ferrara F
Leukemia; 1991 Sep; 5(9):815-8. PubMed ID: 1719310
[No Abstract] [Full Text] [Related]
20. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
